Paul Hastings LLP

Paul Hastings LLP’s China practice routinely handles high-end, late-stage private equity buyout deals. The team covers the full range of investment deals, including strategy, negotiations, fund management, exits and dispositions. In a recent 12-month period, the group was notably active in major private equity deals in the real estate, healthcare, pharmaceutical, TMT and public sectors. Regularly sought out by technology-focused clients, Shanghai and Beijing-based David Wang, who is also admitted to practice in California, focuses on M&A, private equity, joint ventures and capital markets; and Meka Meng in Beijing is experienced in investment transactions, in addition to private equity fund formation, venture capital, M&A, and joint ventures. In May 2024, former partner Jia Yan departed the firm.